Quick Answer
Valion Bio, Inc. reported Total Assets of $31.61 million for fiscal year 2025.
Valion Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $31.61M | +1026.0% |
| 2024 | $2.81M | -45.6% |
| 2023 | $5.16M | -12.2% |
| 2022 | $5.88M | -60.9% |
| 2021 | $15.04M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.23M | +83.5% | +38.2% |
| June 30, 2025 | $4.51M | -5.7% | +19.4% |
| March 31, 2025 | $3.78M | +14.9% | +34.6% |
| December 31, 2024 | $2.81M | -45.6% | -17.3% |
| September 30, 2024 | $3.39M | -51.6% | -29.0% |
| June 30, 2024 | $4.78M | +4.1% | +45.6% |
| March 31, 2024 | $3.29M | -53.7% | -36.3% |
| December 31, 2023 | $5.16M | -11.9% | -26.4% |
- Valion Bio, Inc. showed an increase of +1026.0% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Valion Bio, Inc.’s total assets has grown by 110.2% (from $15.04 million to $31.61 million).
- The most recent figure is from Valion Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: